Clinical Trial Update: A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating human C1 esterase inhibitor for acute antibody-mediated rejection in transplant patients has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Rejection

Drugs mentioned

• C1 Esterase Inhibitor (Human) (C1 Esterase Inhibitor)

Snippet

Sponsor: Shire | Conditions: Graft Rejection | Phase 2 | Status: COMPLETED | Results posted: 2015-07-09